MH has participated in advisory boards and/or symposia for Novo Nordisk, Sanofi, Novartis, Eli Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, Inova and AstraZeneca, and has received honoraria for this activity, and is a shareholder for both Satiogen and Glyscend
High Rates of Meaningful Weight Loss: Virtually all patients on retatrutide saw significant benefits
Patients who sustain the best outcomes view medication not as a temporary tool but as a long-term scaffold supporting lifetime habit changes
It may help dull-looking skin appear clearer and more balanced over time
Value for money Don't let cost put you off from getting the treatment you need
Statistically significant differences were analyzed by one-way analysis of variance